A Real-World, Multicenter, 6-Month Prospective Study in Greece of the Effectiveness and Safety of Ranibizumab in Patients with Age-Related Macular Degeneration Who Have Inadequately Responded to Aflibercept: The “ELEVATE” Study

PURPOSE: Real-world evidence on short-term outcomes of ranibizumab in wet age-related macular degeneration (wAMD) following inadequate response to aflibercept is scarce. This study aimed to evaluate the functional and anatomic effects of switching to ranibizumab in cases of wAMD previously treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouvas, Alexandros, Datseris, Ioannis, Androudi, Sofia, Tsilimbaris, Miltiadis, Kabanarou, Stamatina A, Pharmakakis, Nikolaos, Koutsandrea, Chryssanthi, Charonis, Alexander, Kousidou, Olga, Pantelopoulou, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380822/
https://www.ncbi.nlm.nih.gov/pubmed/35983162
http://dx.doi.org/10.2147/OPTH.S371036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380822/
https://www.ncbi.nlm.nih.gov/pubmed/35983162
http://dx.doi.org/10.2147/OPTH.S371036

Ejemplares similares